Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06820515 · ClinicalTrials.gov registry record
ATHNdataset Registry
A clinical trial, sponsored by American Thrombosis and Hemostasis Network.
- Recruiting
- Registry status
- 200,000
- Enrollment target
NCT06820515 is a clinical trial that is actively recruiting participants, run by American Thrombosis and Hemostasis Network. The registered enrollment target is 200,000 participants.
The verdict
NCT06820515 is actively recruiting participants, sponsored by American Thrombosis and Hemostasis Network.
- RECRUITING
- Registry status
- 200,000 participants
- Enrollment target
Study Summary
The Hemophilia Treatment Center (HTC) where you receive care is working with The American Thrombosis and Hemostasis Network (ATHN) to look at the quality of life of people with blood disorders and problems. Doctors, scientists, policymakers, and other health care providers need a large amount of information from a lot of people to answer scientific, public health, and policy questions about better ways to treat blood disorders. They will use the information from the ATHNdataset to answer these questions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200,000 participants |
| Start Date | 2024-10-25 |
| Est. Completion | 2055-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06820515
The ClinicalTrials.gov registry entry for NCT06820515 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American Thrombosis and Hemostasis Network, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT06820515 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06820515 about?
NCT06820515 is a clinical study titled "ATHNdataset Registry". The Hemophilia Treatment Center (HTC) where you receive care is working with The American Thrombosis and Hemostasis Network (ATHN) to look at the quality of life of people with blood disorders and problems. Doctors, scientists, policymakers, and other health care providers need a large amount of in...
What is the current status of trial NCT06820515?
This trial is currently recruiting. The enrollment target is 200,000 participants. The study started on 2024-10-25. Estimated completion is 2055-10-31.
Who is sponsoring clinical trial NCT06820515?
This trial is sponsored by American Thrombosis and Hemostasis Network, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.